No quarterly revenue total was found in Yorkville Acquisition Corp.'s SEC filings.
Yorkville Acquisition Corp. (MCGA) files with the SEC under industry code 6199, Finance Services.
Revenue
—
Net income
$1.42M
+2402.9% vs year-ago quarter
Operating cash flow
$-128,644
+68.0% vs prior quarter
Free cash flow
—
EPS
—
Dividend per share
None
Shares outstanding
—
Net cash
—
Operating margin
—
Company profile
- Industry
- Finance Services (SIC 6199)
- Listed as
- MCGA (Nasdaq), MCGAU (Nasdaq), MCGAW (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- Mountainside, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 2064658
Other Finance Services companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|
| Operating income | -$181,086 | -$652,277 | -$1.6M | -$63,574 |
| Net income | $1.4M | $943,355 | -$395,372 | -$61,710 |
| Operating cash flow | -$128,644 | -$401,838 | — | — |
| Total assets | $179.9M | $178.3M | $175.2M | $174.9M |
| Total liabilities | $8.0M | $7.7M | $6.6M | $5.9M |
| Stockholders' equity | -$7.6M | -$7.4M | -$6.0M | -$4.4M |
| Cash and investments | $181,617 | $60,261 | $290,238 | $1.5M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 12, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Agreement ended, Other events
|
Aug 10, 2026 | Aug 7, 2026 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jul 15, 2026 | May 4, 2026 |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Officer or director change
|
Apr 24, 2026 | Apr 22, 2026 |
| 10-K | Annual report | Mar 31, 2026 | Dec 31, 2025 |
All 74 Yorkville Acquisition Corp. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.